Venus Remedies gets marketing authorisation for oncology drugs in Ukraine

[ad_1] Venus Remedies has received marketing authorisation for its oncology drugs in Ukraine. This includes Paclitaxel, 100mg/16.7mL, 260mg/43.3mL, 300mg/50mL and 30mg/5mL, Oxaliplatin in concentrations of 50mg/10mL and 100mg/20mL, and Irinotecan in formulations of 100mg/5mL and 40mg/2mL.The company had been awarded...

Venus Remedies receives disbursement of ₹7.5 crore under PLI Scheme, shares trade flat

[ad_1] Venus Remedies Ltd received the first disbursement of ₹7.5 crore under the Government’s Production Linked Incentive (PLl) scheme for the financial year 2022-23, which covers 75% of the total incentive due to the company for the year. The company...